New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
05:55 EDTSPPI, SPPI, WAT, WAT, HSIC, HSIC, ISIS, ISIS, THOR, THOR, GWAY, GWAY, HRC, HRC, HWAY, HWAY, MYGN, MYGN, BMRN, BMRN, DRRX, DRRX, MCK, MCKCredit Suisse to host a conference
2012 Healthcare Conference is being held in Phoenix on November 14-15.
News For MCK;DRRX;BMRN;MYGN;HWAY;HRC;GWAY;THOR;ISIS;HSIC;WAT;SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 26, 2014
10:01 EDTISISOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:20 EDTISISIsis Pharmaceuticals assumed with a Market Perform at Leerink
Subscribe for More Information
September 25, 2014
08:59 EDTISISSummer Street chief scientific officer holds an analyst/industry conference call
Subscribe for More Information
September 24, 2014
17:25 EDTBMRNBioMarin submits Paragraph IV notice letter for Kuvan tablets to the FDA
BioMarin announced that a Paragraph IV Certification Notice Letter was submitted to the FDA in connection with an Abbreviated New Drug Application to the FDA for approval to market a generic version of Kuvan Tablets, although it has not yet received notice of the certification. BioMarin will evaluate the Paragraph IV certification when it receives the Notice Letter and intends to enforce its intellectual property rights. Once the lawsuit is filed, the 30 month stay period will begin as of the date BioMarin was notified of the filing.
10:01 EDTBMRNBioMarin drops 1% after FDA posts Kuvan Paragraph IV Patent challenge
Subscribe for More Information
09:57 EDTBMRNFDA posts Paragraph IV Patent challenge to BioMarin's Kuvan
Subscribe for More Information
September 23, 2014
11:31 EDTHRCHill-Rom announces seven-year, sole-source contract with Providence Health
Subscribe for More Information
09:00 EDTMCKBofa/Merill special situations team to hold an analyst/industry conference call
Subscribe for More Information
September 22, 2014
15:14 EDTISISIsis Pharmaceuticals management to meet with JPMorgan
Meeting to be held in Los Angeles on September 22 hosted by JPMorgan.
11:48 EDTSPPISpectrum management to meet with Roth Capital
Subscribe for More Information
07:35 EDTTHORThoratec sees Q3 revenue $102M-$107M, consensus $109.54M
Subscribe for More Information
07:34 EDTTHORThoratec appoints Keith Grossman President and CEO
Subscribe for More Information
September 18, 2014
12:18 EDTBMRNPiper Jaffray biopharm analyst holds an analyst/industry conference call
Subscribe for More Information
11:55 EDTMCKRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
09:02 EDTMCKRite Aid sees current competitive enviornment to remain promotional in FY15
Subscribe for More Information
07:07 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
September 17, 2014
11:41 EDTTHORLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
07:43 EDTBMRNBofA/Merrill to hold a conference
Subscribe for More Information
07:29 EDTISISIsis Pharmaceuticals earns $4M from Achaogen for Phase 3 study of plazomicin
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use